img

Global Botulinum Toxin Type A Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Botulinum Toxin Type A Market Insights, Forecast to 2034

Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
The global Botulinum Toxin Type A market is projected to grow from US$ 6820 million in 2023 to US$ 8335.1 million by 2033, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
In terms of production side, this report researches the Botulinum Toxin Type A production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2033.
In terms of consumption side, this report focuses on the sales of Botulinum Toxin Type A by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2033.

Report Includes


This report presents an overview of global market for Botulinum Toxin Type A, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of Botulinum Toxin Type A, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Botulinum Toxin Type A, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Botulinum Toxin Type A sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Botulinum Toxin Type A market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2033. Evaluation and forecast the market size for Botulinum Toxin Type A sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ALLERGAN, Galderma, Merz Pharma, DAEWOONG, Ipsen and Pfizer, etc.



By Company


ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
Segment by Type
50 Units
100 Units
200 Units

Segment by Application


Cosmetic Applications
Therapeutic Applications
Others

Production by Region


North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Botulinum Toxin Type A production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3Sales (consumption), revenue of Botulinum Toxin Type A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4Detailed analysis of Botulinum Toxin Type A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9China by type and by application sales and revenue for each segment.
Chapter 10Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botulinum Toxin Type A sales, revenue, price, gross margin, and recent development, etc.
Chapter 13Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Botulinum Toxin Type A Product Introduction
1.2 Market by Type
1.2.1 Global Botulinum Toxin Type A Market Size by Type, 2018 VS 2022 VS 2033
1.2.2 50 Units
1.2.3 100 Units
1.2.4 200 Units
1.3 Market by Application
1.3.1 Global Botulinum Toxin Type A Market Size by Application, 2018 VS 2022 VS 2033
1.3.2 Cosmetic Applications
1.3.3 Therapeutic Applications
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Botulinum Toxin Type A Production
2.1 Global Botulinum Toxin Type A Production Capacity (2018-2033)
2.2 Global Botulinum Toxin Type A Production by Region: 2018 VS 2022 VS 2033
2.3 Global Botulinum Toxin Type A Production by Region
2.3.1 Global Botulinum Toxin Type A Historic Production by Region (2018-2023)
2.3.2 Global Botulinum Toxin Type A Forecasted Production by Region (2024-2033)
2.3.3 Global Botulinum Toxin Type A Production Market Share by Region (2018-2033)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Botulinum Toxin Type A Revenue Estimates and Forecasts 2018-2033
3.2 Global Botulinum Toxin Type A Revenue by Region
3.2.1 Global Botulinum Toxin Type A Revenue by Region: 2018 VS 2022 VS 2033
3.2.2 Global Botulinum Toxin Type A Revenue by Region (2018-2023)
3.2.3 Global Botulinum Toxin Type A Revenue by Region (2024-2033)
3.2.4 Global Botulinum Toxin Type A Revenue Market Share by Region (2018-2033)
3.3 Global Botulinum Toxin Type A Sales Estimates and Forecasts 2018-2033
3.4 Global Botulinum Toxin Type A Sales by Region
3.4.1 Global Botulinum Toxin Type A Sales by Region: 2018 VS 2022 VS 2033
3.4.2 Global Botulinum Toxin Type A Sales by Region (2018-2023)
3.4.3 Global Botulinum Toxin Type A Sales by Region (2024-2033)
3.4.4 Global Botulinum Toxin Type A Sales Market Share by Region (2018-2033)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Botulinum Toxin Type A Sales by Manufacturers
4.1.1 Global Botulinum Toxin Type A Sales by Manufacturers (2018-2023)
4.1.2 Global Botulinum Toxin Type A Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Botulinum Toxin Type A in 2022
4.2 Global Botulinum Toxin Type A Revenue by Manufacturers
4.2.1 Global Botulinum Toxin Type A Revenue by Manufacturers (2018-2023)
4.2.2 Global Botulinum Toxin Type A Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Botulinum Toxin Type A Revenue in 2022
4.3 Global Botulinum Toxin Type A Sales Price by Manufacturers
4.4 Global Key Players of Botulinum Toxin Type A, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Botulinum Toxin Type A Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Botulinum Toxin Type A, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Botulinum Toxin Type A, Product Offered and Application
4.8 Global Key Manufacturers of Botulinum Toxin Type A, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Botulinum Toxin Type A Sales by Type
5.1.1 Global Botulinum Toxin Type A Historical Sales by Type (2018-2023)
5.1.2 Global Botulinum Toxin Type A Forecasted Sales by Type (2024-2033)
5.1.3 Global Botulinum Toxin Type A Sales Market Share by Type (2018-2033)
5.2 Global Botulinum Toxin Type A Revenue by Type
5.2.1 Global Botulinum Toxin Type A Historical Revenue by Type (2018-2023)
5.2.2 Global Botulinum Toxin Type A Forecasted Revenue by Type (2024-2033)
5.2.3 Global Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
5.3 Global Botulinum Toxin Type A Price by Type
5.3.1 Global Botulinum Toxin Type A Price by Type (2018-2023)
5.3.2 Global Botulinum Toxin Type A Price Forecast by Type (2024-2033)
6 Market Size by Application
6.1 Global Botulinum Toxin Type A Sales by Application
6.1.1 Global Botulinum Toxin Type A Historical Sales by Application (2018-2023)
6.1.2 Global Botulinum Toxin Type A Forecasted Sales by Application (2024-2033)
6.1.3 Global Botulinum Toxin Type A Sales Market Share by Application (2018-2033)
6.2 Global Botulinum Toxin Type A Revenue by Application
6.2.1 Global Botulinum Toxin Type A Historical Revenue by Application (2018-2023)
6.2.2 Global Botulinum Toxin Type A Forecasted Revenue by Application (2024-2033)
6.2.3 Global Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
6.3 Global Botulinum Toxin Type A Price by Application
6.3.1 Global Botulinum Toxin Type A Price by Application (2018-2023)
6.3.2 Global Botulinum Toxin Type A Price Forecast by Application (2024-2033)
7 US & Canada
7.1 US & Canada Botulinum Toxin Type A Market Size by Type
7.1.1 US & Canada Botulinum Toxin Type A Sales by Type (2018-2033)
7.1.2 US & Canada Botulinum Toxin Type A Revenue by Type (2018-2033)
7.2 US & Canada Botulinum Toxin Type A Market Size by Application
7.2.1 US & Canada Botulinum Toxin Type A Sales by Application (2018-2033)
7.2.2 US & Canada Botulinum Toxin Type A Revenue by Application (2018-2033)
7.3 US & Canada Botulinum Toxin Type A Sales by Country
7.3.1 US & Canada Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 US & Canada Botulinum Toxin Type A Sales by Country (2018-2033)
7.3.3 US & Canada Botulinum Toxin Type A Revenue by Country (2018-2033)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Botulinum Toxin Type A Market Size by Type
8.1.1 Europe Botulinum Toxin Type A Sales by Type (2018-2033)
8.1.2 Europe Botulinum Toxin Type A Revenue by Type (2018-2033)
8.2 Europe Botulinum Toxin Type A Market Size by Application
8.2.1 Europe Botulinum Toxin Type A Sales by Application (2018-2033)
8.2.2 Europe Botulinum Toxin Type A Revenue by Application (2018-2033)
8.3 Europe Botulinum Toxin Type A Sales by Country
8.3.1 Europe Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033
8.3.2 Europe Botulinum Toxin Type A Sales by Country (2018-2033)
8.3.3 Europe Botulinum Toxin Type A Revenue by Country (2018-2033)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Botulinum Toxin Type A Market Size by Type
9.1.1 China Botulinum Toxin Type A Sales by Type (2018-2033)
9.1.2 China Botulinum Toxin Type A Revenue by Type (2018-2033)
9.2 China Botulinum Toxin Type A Market Size by Application
9.2.1 China Botulinum Toxin Type A Sales by Application (2018-2033)
9.2.2 China Botulinum Toxin Type A Revenue by Application (2018-2033)
10 Asia (excluding China)
10.1 Asia Botulinum Toxin Type A Market Size by Type
10.1.1 Asia Botulinum Toxin Type A Sales by Type (2018-2033)
10.1.2 Asia Botulinum Toxin Type A Revenue by Type (2018-2033)
10.2 Asia Botulinum Toxin Type A Market Size by Application
10.2.1 Asia Botulinum Toxin Type A Sales by Application (2018-2033)
10.2.2 Asia Botulinum Toxin Type A Revenue by Application (2018-2033)
10.3 Asia Botulinum Toxin Type A Sales by Region
10.3.1 Asia Botulinum Toxin Type A Revenue by Region: 2018 VS 2022 VS 2033
10.3.2 Asia Botulinum Toxin Type A Revenue by Region (2018-2033)
10.3.3 Asia Botulinum Toxin Type A Sales by Region (2018-2033)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Botulinum Toxin Type A Market Size by Type
11.1.1 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Type (2018-2033)
11.1.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Type (2018-2033)
11.2 Middle East, Africa and Latin America Botulinum Toxin Type A Market Size by Application
11.2.1 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Application (2018-2033)
11.2.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Application (2018-2033)
11.3 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Country
11.3.1 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country: 2018 VS 2022 VS 2033
11.3.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country (2018-2033)
11.3.3 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Country (2018-2033)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 ALLERGAN
12.1.1 ALLERGAN Company Information
12.1.2 ALLERGAN Overview
12.1.3 ALLERGAN Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 ALLERGAN Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 ALLERGAN Recent Developments
12.2 Galderma
12.2.1 Galderma Company Information
12.2.2 Galderma Overview
12.2.3 Galderma Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Galderma Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Galderma Recent Developments
12.3 Merz Pharma
12.3.1 Merz Pharma Company Information
12.3.2 Merz Pharma Overview
12.3.3 Merz Pharma Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Merz Pharma Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Merz Pharma Recent Developments
12.4 DAEWOONG
12.4.1 DAEWOONG Company Information
12.4.2 DAEWOONG Overview
12.4.3 DAEWOONG Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 DAEWOONG Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 DAEWOONG Recent Developments
12.5 Ipsen
12.5.1 Ipsen Company Information
12.5.2 Ipsen Overview
12.5.3 Ipsen Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Ipsen Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Ipsen Recent Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Overview
12.6.3 Pfizer Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Pfizer Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Pfizer Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Botulinum Toxin Type A Industry Chain Analysis
13.2 Botulinum Toxin Type A Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Botulinum Toxin Type A Production Mode & Process
13.4 Botulinum Toxin Type A Sales and Marketing
13.4.1 Botulinum Toxin Type A Sales Channels
13.4.2 Botulinum Toxin Type A Distributors
13.5 Botulinum Toxin Type A Customers
14 Botulinum Toxin Type A Market Dynamics
14.1 Botulinum Toxin Type A Industry Trends
14.2 Botulinum Toxin Type A Market Drivers
14.3 Botulinum Toxin Type A Market Challenges
14.4 Botulinum Toxin Type A Market Restraints
15 Key Finding in The Global Botulinum Toxin Type A Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Botulinum Toxin Type A Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of 50 Units
Table 3. Major Manufacturers of 100 Units
Table 4. Major Manufacturers of 200 Units
Table 5. Global Botulinum Toxin Type A Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global Botulinum Toxin Type A Production by Region: 2018 VS 2022 VS 2033 (K MT)
Table 7. Global Botulinum Toxin Type A Production by Region (2018-2023) & (K MT)
Table 8. Global Botulinum Toxin Type A Production by Region (2024-2033) & (K MT)
Table 9. Global Botulinum Toxin Type A Production Market Share by Region (2018-2023)
Table 10. Global Botulinum Toxin Type A Production Market Share by Region (2024-2033)
Table 11. Global Botulinum Toxin Type A Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 12. Global Botulinum Toxin Type A Revenue by Region (2018-2023) & (US$ Million)
Table 13. Global Botulinum Toxin Type A Revenue by Region (2024-2033) & (US$ Million)
Table 14. Global Botulinum Toxin Type A Revenue Market Share by Region (2018-2023)
Table 15. Global Botulinum Toxin Type A Revenue Market Share by Region (2024-2033)
Table 16. Global Botulinum Toxin Type A Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 17. Global Botulinum Toxin Type A Sales by Region (2018-2023) & (K MT)
Table 18. Global Botulinum Toxin Type A Sales by Region (2024-2033) & (K MT)
Table 19. Global Botulinum Toxin Type A Sales Market Share by Region (2018-2023)
Table 20. Global Botulinum Toxin Type A Sales Market Share by Region (2024-2033)
Table 21. Global Botulinum Toxin Type A Sales by Manufacturers (2018-2023) & (K MT)
Table 22. Global Botulinum Toxin Type A Sales Share by Manufacturers (2018-2023)
Table 23. Global Botulinum Toxin Type A Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 24. Global Botulinum Toxin Type A Revenue Share by Manufacturers (2018-2023)
Table 25. Botulinum Toxin Type A Price by Manufacturers 2018-2023 (USD/MT)
Table 26. Global Key Players of Botulinum Toxin Type A, Industry Ranking, 2021 VS 2022 VS 2023
Table 27. Global Botulinum Toxin Type A Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Botulinum Toxin Type A by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botulinum Toxin Type A as of 2022)
Table 29. Global Key Manufacturers of Botulinum Toxin Type A, Manufacturing Base Distribution and Headquarters
Table 30. Global Key Manufacturers of Botulinum Toxin Type A, Product Offered and Application
Table 31. Global Key Manufacturers of Botulinum Toxin Type A, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Botulinum Toxin Type A Sales by Type (2018-2023) & (K MT)
Table 34. Global Botulinum Toxin Type A Sales by Type (2024-2033) & (K MT)
Table 35. Global Botulinum Toxin Type A Sales Share by Type (2018-2023)
Table 36. Global Botulinum Toxin Type A Sales Share by Type (2024-2033)
Table 37. Global Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 38. Global Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 39. Global Botulinum Toxin Type A Revenue Share by Type (2018-2023)
Table 40. Global Botulinum Toxin Type A Revenue Share by Type (2024-2033)
Table 41. Botulinum Toxin Type A Price by Type (2018-2023) & (USD/MT)
Table 42. Global Botulinum Toxin Type A Price Forecast by Type (2024-2033) & (USD/MT)
Table 43. Global Botulinum Toxin Type A Sales by Application (2018-2023) & (K MT)
Table 44. Global Botulinum Toxin Type A Sales by Application (2024-2033) & (K MT)
Table 45. Global Botulinum Toxin Type A Sales Share by Application (2018-2023)
Table 46. Global Botulinum Toxin Type A Sales Share by Application (2024-2033)
Table 47. Global Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 48. Global Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 49. Global Botulinum Toxin Type A Revenue Share by Application (2018-2023)
Table 50. Global Botulinum Toxin Type A Revenue Share by Application (2024-2033)
Table 51. Botulinum Toxin Type A Price by Application (2018-2023) & (USD/MT)
Table 52. Global Botulinum Toxin Type A Price Forecast by Application (2024-2033) & (USD/MT)
Table 53. US & Canada Botulinum Toxin Type A Sales by Type (2018-2023) & (K MT)
Table 54. US & Canada Botulinum Toxin Type A Sales by Type (2024-2033) & (K MT)
Table 55. US & Canada Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 56. US & Canada Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 57. US & Canada Botulinum Toxin Type A Sales by Application (2018-2023) & (K MT)
Table 58. US & Canada Botulinum Toxin Type A Sales by Application (2024-2033) & (K MT)
Table 59. US & Canada Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 60. US & Canada Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 61. US & Canada Botulinum Toxin Type A Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 62. US & Canada Botulinum Toxin Type A Revenue by Country (2018-2023) & (US$ Million)
Table 63. US & Canada Botulinum Toxin Type A Revenue by Country (2024-2033) & (US$ Million)
Table 64. US & Canada Botulinum Toxin Type A Sales by Country (2018-2023) & (K MT)
Table 65. US & Canada Botulinum Toxin Type A Sales by Country (2024-2033) & (K MT)
Table 66. Europe Botulinum Toxin Type A Sales by Type (2018-2023) & (K MT)
Table 67. Europe Botulinum Toxin Type A Sales by Type (2024-2033) & (K MT)
Table 68. Europe Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 70. Europe Botulinum Toxin Type A Sales by Application (2018-2023) & (K MT)
Table 71. Europe Botulinum Toxin Type A Sales by Application (2024-2033) & (K MT)
Table 72. Europe Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 74. Europe Botulinum Toxin Type A Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 75. Europe Botulinum Toxin Type A Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Botulinum Toxin Type A Revenue by Country (2024-2033) & (US$ Million)
Table 77. Europe Botulinum Toxin Type A Sales by Country (2018-2023) & (K MT)
Table 78. Europe Botulinum Toxin Type A Sales by Country (2024-2033) & (K MT)
Table 79. China Botulinum Toxin Type A Sales by Type (2018-2023) & (K MT)
Table 80. China Botulinum Toxin Type A Sales by Type (2024-2033) & (K MT)
Table 81. China Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 83. China Botulinum Toxin Type A Sales by Application (2018-2023) & (K MT)
Table 84. China Botulinum Toxin Type A Sales by Application (2024-2033) & (K MT)
Table 85. China Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 87. Asia Botulinum Toxin Type A Sales by Type (2018-2023) & (K MT)
Table 88. Asia Botulinum Toxin Type A Sales by Type (2024-2033) & (K MT)
Table 89. Asia Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 90. Asia Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 91. Asia Botulinum Toxin Type A Sales by Application (2018-2023) & (K MT)
Table 92. Asia Botulinum Toxin Type A Sales by Application (2024-2033) & (K MT)
Table 93. Asia Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 94. Asia Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 95. Asia Botulinum Toxin Type A Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 96. Asia Botulinum Toxin Type A Revenue by Region (2018-2023) & (US$ Million)
Table 97. Asia Botulinum Toxin Type A Revenue by Region (2024-2033) & (US$ Million)
Table 98. Asia Botulinum Toxin Type A Sales by Region (2018-2023) & (K MT)
Table 99. Asia Botulinum Toxin Type A Sales by Region (2024-2033) & (K MT)
Table 100. Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Type (2018-2023) & (K MT)
Table 101. Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Type (2024-2033) & (K MT)
Table 102. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Type (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Type (2024-2033) & (US$ Million)
Table 104. Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Application (2018-2023) & (K MT)
Table 105. Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Application (2024-2033) & (K MT)
Table 106. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Application (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Application (2024-2033) & (US$ Million)
Table 108. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 109. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country (2024-2033) & (US$ Million)
Table 111. Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Country (2018-2023) & (K MT)
Table 112. Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Country (2024-2033) & (K MT)
Table 113. ALLERGAN Company Information
Table 114. ALLERGAN Description and Major Businesses
Table 115. ALLERGAN Botulinum Toxin Type A Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 116. ALLERGAN Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. ALLERGAN Recent Development
Table 118. Galderma Company Information
Table 119. Galderma Description and Major Businesses
Table 120. Galderma Botulinum Toxin Type A Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 121. Galderma Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Galderma Recent Development
Table 123. Merz Pharma Company Information
Table 124. Merz Pharma Description and Major Businesses
Table 125. Merz Pharma Botulinum Toxin Type A Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 126. Merz Pharma Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Merz Pharma Recent Development
Table 128. DAEWOONG Company Information
Table 129. DAEWOONG Description and Major Businesses
Table 130. DAEWOONG Botulinum Toxin Type A Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 131. DAEWOONG Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. DAEWOONG Recent Development
Table 133. Ipsen Company Information
Table 134. Ipsen Description and Major Businesses
Table 135. Ipsen Botulinum Toxin Type A Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 136. Ipsen Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Ipsen Recent Development
Table 138. Pfizer Company Information
Table 139. Pfizer Description and Major Businesses
Table 140. Pfizer Botulinum Toxin Type A Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 141. Pfizer Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Pfizer Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Botulinum Toxin Type A Distributors List
Table 146. Botulinum Toxin Type A Customers List
Table 147. Botulinum Toxin Type A Market Trends
Table 148. Botulinum Toxin Type A Market Drivers
Table 149. Botulinum Toxin Type A Market Challenges
Table 150. Botulinum Toxin Type A Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Botulinum Toxin Type A Product Picture
Figure 2. Global Botulinum Toxin Type A Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Botulinum Toxin Type A Market Share by Type in 2022 & 2033
Figure 4. 50 Units Product Picture
Figure 5. 100 Units Product Picture
Figure 6. 200 Units Product Picture
Figure 7. Global Botulinum Toxin Type A Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Botulinum Toxin Type A Market Share by Application in 2022 & 2033
Figure 9. Cosmetic Applications
Figure 10. Therapeutic Applications
Figure 11. Others
Figure 12. Botulinum Toxin Type A Report Years Considered
Figure 13. Global Botulinum Toxin Type A Capacity, Production and Utilization (2018-2033) & (K MT)
Figure 14. Global Botulinum Toxin Type A Production Market Share by Region in Percentage: 2022 Versus 2033
Figure 15. Global Botulinum Toxin Type A Production Market Share by Region (2018-2033)
Figure 16. Botulinum Toxin Type A Production Growth Rate in North America (2018-2033) & (K MT)
Figure 17. Botulinum Toxin Type A Production Growth Rate in Europe (2018-2033) & (K MT)
Figure 18. Botulinum Toxin Type A Production Growth Rate in China (2018-2033) & (K MT)
Figure 19. Botulinum Toxin Type A Production Growth Rate in Japan (2018-2033) & (K MT)
Figure 20. Global Botulinum Toxin Type A Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 21. Global Botulinum Toxin Type A Revenue 2018-2033 (US$ Million)
Figure 22. Global Botulinum Toxin Type A Revenue (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Figure 23. Global Botulinum Toxin Type A Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 24. Global Botulinum Toxin Type A Revenue Market Share by Region (2018-2033)
Figure 25. Global Botulinum Toxin Type A Sales 2018-2033 ((K MT)
Figure 26. Global Botulinum Toxin Type A Sales (CAGR) by Region: 2018 VS 2022 VS 2033 (K MT)
Figure 27. Global Botulinum Toxin Type A Sales Market Share by Region (2018-2033)
Figure 28. US & Canada Botulinum Toxin Type A Sales YoY (2018-2033) & (K MT)
Figure 29. US & Canada Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 30. Europe Botulinum Toxin Type A Sales YoY (2018-2033) & (K MT)
Figure 31. Europe Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 32. China Botulinum Toxin Type A Sales YoY (2018-2033) & (K MT)
Figure 33. China Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 34. Asia (excluding China) Botulinum Toxin Type A Sales YoY (2018-2033) & (K MT)
Figure 35. Asia (excluding China) Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 36. Middle East, Africa and Latin America Botulinum Toxin Type A Sales YoY (2018-2033) & (K MT)
Figure 37. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue YoY (2018-2033) & (US$ Million)
Figure 38. The Botulinum Toxin Type A Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 39. The Top 5 and 10 Largest Manufacturers of Botulinum Toxin Type A in the World: Market Share by Botulinum Toxin Type A Revenue in 2022
Figure 40. Global Botulinum Toxin Type A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 41. Global Botulinum Toxin Type A Sales Market Share by Type (2018-2033)
Figure 42. Global Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 43. Global Botulinum Toxin Type A Sales Market Share by Application (2018-2033)
Figure 44. Global Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 45. US & Canada Botulinum Toxin Type A Sales Market Share by Type (2018-2033)
Figure 46. US & Canada Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 47. US & Canada Botulinum Toxin Type A Sales Market Share by Application (2018-2033)
Figure 48. US & Canada Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 49. US & Canada Botulinum Toxin Type A Revenue Share by Country (2018-2033)
Figure 50. US & Canada Botulinum Toxin Type A Sales Share by Country (2018-2033)
Figure 51. U.S. Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 52. Canada Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 53. Europe Botulinum Toxin Type A Sales Market Share by Type (2018-2033)
Figure 54. Europe Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 55. Europe Botulinum Toxin Type A Sales Market Share by Application (2018-2033)
Figure 56. Europe Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 57. Europe Botulinum Toxin Type A Revenue Share by Country (2018-2033)
Figure 58. Europe Botulinum Toxin Type A Sales Share by Country (2018-2033)
Figure 59. Germany Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 60. France Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 61. U.K. Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 62. Italy Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 63. Russia Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 64. China Botulinum Toxin Type A Sales Market Share by Type (2018-2033)
Figure 65. China Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 66. China Botulinum Toxin Type A Sales Market Share by Application (2018-2033)
Figure 67. China Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 68. Asia Botulinum Toxin Type A Sales Market Share by Type (2018-2033)
Figure 69. Asia Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 70. Asia Botulinum Toxin Type A Sales Market Share by Application (2018-2033)
Figure 71. Asia Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 72. Asia Botulinum Toxin Type A Revenue Share by Region (2018-2033)
Figure 73. Asia Botulinum Toxin Type A Sales Share by Region (2018-2033)
Figure 74. Japan Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 75. South Korea Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 76. China Taiwan Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 77. Southeast Asia Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 78. India Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Market Share by Type (2018-2033)
Figure 80. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue Market Share by Type (2018-2033)
Figure 81. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Market Share by Application (2018-2033)
Figure 82. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue Market Share by Application (2018-2033)
Figure 83. Middle East, Africa and Latin America Botulinum Toxin Type A Revenue Share by Country (2018-2033)
Figure 84. Middle East, Africa and Latin America Botulinum Toxin Type A Sales Share by Country (2018-2033)
Figure 85. Brazil Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 86. Mexico Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 87. Turkey Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 88. Israel Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 89. GCC Countries Botulinum Toxin Type A Revenue (2018-2033) & (US$ Million)
Figure 90. Botulinum Toxin Type A Value Chain
Figure 91. Botulinum Toxin Type A Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed